Abiopharma

News list

Flowers Lee 🟢 acquired 1.4K shares (1 derivative) of HCW Biologics Inc. (HCWB) at $26.00 Transaction Date: May 07, 2025 | Filing ID: 068275

Full text

News bot Sept. 18, 2025, 5:15 a.m.
🔍 Flowers Lee (Executive)

Company: HCW Biologics Inc. (HCWB)

Report Date: 2025-05-07
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 1,443
Detailed Transactions and Holdings:
- Acquired 962 shares of Common Stock at $26.0 per share (Direct)
  Date: 2025-05-08 | Code: P | equity_swap_involved: false | shares_owned_after: 5,720.00 | transaction_form_type: 4 | Footnotes: F1
- Acquired 481 shares of Common Stock Purchase Warrant at $26.0 per share (Derivative)
  Date: 2025-05-07 | Code: P | Expires: 2030-05-07 | Exercise: 2025-05-07 | equity_swap_involved: false | shares_owned_after: 481.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: These shares are being issued as a portion of and pursuant to the Company entering into a definitive conversion agreement on May 1, 2025, with a conversion date of May 7, 2025, along with 13 other holders of $6.6 million of the outstanding principal of the Secured Notes to convert the Secured Notes for an aggregate of 253,083 shares of the Company's Common Stock at a conversion price of $26.00 per share (on a post-reverse split basis), issuance of an aggregate of 126,540 warrants each exercisable for one share of Common Stock at an exercise price of $26.00 per share (on a post-reverse split basis), and a portion of the 2,174,311 shares of Wugen Inc. common stock held by the Company.